The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Asymmetric Dimethylarginine, L-Arginine, and Endothelial Dysfunction in Essential Hypertension
Open accessAbstract
OBJECTIVES We investigated the relationship between ADMA plasma levels and endothelium-dependent vasodilation in 36 never-treated essential hypertensives and in 8 normotensive healthy subjects. BACKGROUND It has been demonstrated that endothelium-dependent vasodilatation is impaired in essential hypertension. The potential contribution of asymmetric dimethylarginine (ADMA) to endothelial dysfunction of hypertensive humans has received poor attention. METHODS Endothelial function was measured during intra-arterial infusion of acetylcholine (ACh), alone and during co-infusion of L-arginine, and sodium nitroprusside at increasing doses. Concentrations of ADMA and L-arginine in plasma were measured by high-performance liquid chromatography. RESULTS Hypertensive subjects had significantly higher ADMA and L-arginine plasma concentrations than normotensive healthy controls; ACh-stimulated forearm blood flow (FBF) was significantly reduced in hypertensive subjects in comparison to normotensive control subjects (p < 0.0001). Intra-arterial coinfusion of L-arginine induced a further significant enhancement in ACh-stimulated vasodilation in hypertensive patients. In these, ADMA was strongly and inversely associated with the peak increase in FBF. In a multivariate model, only ADMA and L-arginine were independent correlates, accounting for 33.9% and 8.9% of the variability in the peak FBF response to ACh (p < 0.0001), respectively. CONCLUSIONS The main finding in this study is that in essential hypertensives the L-arginine and endogenous inhibitor of nitric oxide synthase, ADMA, are inversely related to endothelial function.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Atherosclerosis--an inflammatory disease
Ross, R. (1999) · New England Journal of Medicine · doi:10.1056/nejm199901143400207 · Cited by 21,725
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201303260506 · Cited by 3,725
The Pathogenesis of Coronary Artery Disease and the Acute Coronary Syndromes
Epstein, F. H., Fuster, V., Badimon, L., Badimon, J. J., & Chesebro, J. H. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201233260406 · Cited by 2,717
Abnormal Endothelium-Dependent Vascular Relaxation in Patients with Essential Hypertension
Panza, J. A., Quyyumi, A. A., Brush, J. E., & Epstein, S. E. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230105 · Cited by 2,367
Accumulation of an endogenous inhibitor of nitric oxide synthesis in chronic renal failure
Leone, A., Moncada, S., Vallance, P., Calver, A., & Collier, J. (1992) · The Lancet · doi:10.1016/0140-6736(92)90865-z · Cited by 2,107
The pathogenesis of coronary artery disease and the acute coronary syndromes (First of two parts)
Fuster, V. (1992) · New England Journal of Medicine · Cited by 1,954
Regulatory Functions of the Vascular Endothelium
Epstein, F. H., Vane, J. R., Änggård, E. E., & Botting, R. M. (1990) · New England Journal of Medicine · doi:10.1056/nejm199007053230106 · Cited by 1,889
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Prognostic Significance of Endothelial Dysfunction in Hypertensive Patients
Perticone, F., Ceravolo, R., Pujia, A., Ventura, G., Iacopino, S., Scozzafava, A., Ferraro, A., Chello, M., Mastroroberto, P., Verdecchia, P., et al. (2001) · Circulation · doi:10.1161/01.cir.104.2.191 · Cited by 1,059
Self-citationImpaired vasodilation of forearm resistance vessels in hypercholesterolemic humans.
Creager, M. A., Cooke, J. P., Mendelsohn, M. E., Gallagher, S. J., Coleman, S. M., Loscalzo, J., & Dzau, V. J. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114688 · Cited by 1,017
Zeng, G., Nystrom, F. H., Ravichandran, L. V., Cong, L.-N., Kirby, M., Mostowski, H., & Quon, M. J. (2000) · Circulation · doi:10.1161/01.cir.101.13.1539 · Cited by 745
Achan, V., Broadhead, M., Malaki, M., Whitley, G., Leiper, J., MacAllister, R., & Vallance, P. (2003) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.0000081742.92006.59 · Cited by 593
Vasodilation to acetylcholine in primary and secondary forms of human hypertension.
Taddei, S., Virdis, A., Mattei, P., & Salvetti, A. (1993) · Hypertension · doi:10.1161/01.hyp.21.6.929 · Cited by 535
The Endothelium: Modulator of Cardiovascular Function
Lüscher, T. F., & Vanhoutte, P. M. (2020) · CRC Press eBooks · doi:10.1201/9780429281808 · Cited by 527
Long-term Cigarette Smoking Impairs Endothelium-Dependent Coronary Arterial Vasodilator Function
Zeiher, A. M., Schächinger, V., & Minners, J. (1995) · Circulation · doi:10.1161/01.cir.92.5.1094 · Cited by 495
Böger, R. H., Bode-Böger, S. M., Thiele, W., Junker, W., Alexander, K., & Frölich, J. C. (1997) · Circulation · doi:10.1161/01.cir.95.8.2068 · Cited by 490
Self-citationSurdacki, A., Nowicki, M., Sandmann, J., Tsikas, D., Boeger, R. H., Bode-Boeger, S. M., Kruszelnicka-Kwiatkowska, O., Kokot, F., Dubiel, J. S., & Froelich, J. C. (1999) · Journal of Cardiovascular Pharmacology · doi:10.1097/00005344-199904000-00020 · Cited by 426
Endothelial function in health and disease: new insights into the genesis of cardiovascular disease
Quyyumi, A. A. (1998) · The American Journal of Medicine · doi:10.1016/s0002-9343(98)00209-5 · Cited by 406
Asymmetrical Dimethylarginine: The Über Marker?
Cooke, J. P. (2004) · Circulation · doi:10.1161/01.cir.0000126823.07732.d5 · Cited by 396
The emerging role of asymmetric dimethylarginine as a novel cardiovascular risk factor
BOGER, R. (2003) · Cardiovascular Research · doi:10.1016/s0008-6363(03)00500-5 · Cited by 393
Self-citationObesity and Body Fat Distribution Induce Endothelial Dysfunction by Oxidative Stress
Perticone, F., Ceravolo, R., Candigliota, M., Ventura, G., Iacopino, S., Sinopoli, F., & Mattioli, P. L. (2001) · Diabetes · doi:10.2337/diabetes.50.1.159 · Cited by 338
Self-citationNitric oxide functions as an inhibitor of platelet adhesion under flow conditions.
de Graaf, J. C., Banga, J. D., Moncada, S., Palmer, R. M., de Groot, P. G., & Sixma, J. J. (1992) · Circulation · doi:10.1161/01.cir.85.6.2284 · Cited by 337
Endothelial Dysfunction Induced by Hyperhomocyst(e)inemia: Role of Asymmetric Dimethylarginine
Stühlinger, M. C., Oka, R. K., Graf, E. E., Schmölzer, I., Upson, B. M., Kapoor, O., Szuba, A., Malinow, M. R., Wascher, T. C., Pachinger, O., et al. (2003) · Circulation · doi:10.1161/01.cir.0000085067.55901.89 · Cited by 303
Nitric oxide and the proliferation of vascular smooth muscle cells
Jeremy, J. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00171-6 · Cited by 285
Decreased Arginine Bioavailability and Increased Serum Arginase Activity in Asthma
Morris, C. R., Poljakovic, M., Lavrisha, L., Machado, L., Kuypers, F. A., & Morris, S. M. (2004) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200309-1304oc · Cited by 283
Fujiwara, N., Osanai, T., Kamada, T., Katoh, T., Takahashi, K., & Okumura, K. (2000) · Circulation · doi:10.1161/01.cir.101.8.856 · Cited by 242
Fard, A., Tuck, C. H., Donis, J. A., Sciacca, R., Di Tullio, M. R., Wu, H. D., Bryant, T. A., Chen, N.-T., Torres-Tamayo, M., Ramasamy, R., et al. (2000) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.20.9.2039 · Cited by 221
BÖGER, R. H., LENTZ, S. R., BODE-BÖGER, S. M., KNAPP, H. R., & HAYNES, W. G. (2001) · Clinical Science · doi:10.1042/cs1000161 · Cited by 204
Arnal, J. F., Münzel, T., Venema, R. C., James, N. L., Bai, C. L., Mitch, W. E., & Harrison, D. G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117957 · Cited by 181
Lu, T.-M., Ding, Y.-A., Leu, H.-B., Yin, W.-H., Sheu, W. H.-H., & Chu, K.-M. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2004.03.052 · Cited by 163
MacAllister, R. J., Fickling, S. A., Whitley, G. S. J., & Vallance, P. (1994) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1994.tb13026.x · Cited by 162
Chao, C., Kuo, T., & Lee, Y. (2000) · Circulation · doi:10.1161/01.cir.101.5.485 · Cited by 146
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.
Cooke, J. P., & Dzau, V. J. (1997) · PubMed · Cited by 136
Palloshi, A., Fragasso, G., Piatti, P., Monti, L. D., Setola, E., Valsecchi, G., Galluccio, E., Chierchia, S. L., & Margonato, A. (2004) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2003.12.040 · Cited by 130
Effect of Shear Stress on Asymmetric Dimethylarginine Release From Vascular Endothelial Cells
Osanai, T., Saitoh, M., Sasaki, S., Tomita, H., Matsunaga, T., & Okumura, K. (2003) · Hypertension · doi:10.1161/01.hyp.0000097805.05108.16 · Cited by 115
Thorne, S., Mullen, M., Clarkson, P., Donald, A. E., & Deanfield, J. E. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00211-3 · Cited by 108
Bogle, R., Baydoun, A. R., Pearson, J. D., & Mann, G. E. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021138 · Cited by 103
Calver, A., Collier, J., Leone, A., Moncada, S., & Vallance, P. J. (1993) · PubMed · Cited by 100
Diminished L -arginine bioavailability in hypertension
Moss, M. B., Brunini, T. M. C., de Moura, R. S., Malagris, L. E. N., ROBERTS, N. B., Ellory, J. C., Mann, G. E., & Ribeiro, A. C. M. (2004) · Clinical Science · doi:10.1042/cs20030412 · Cited by 92
INCREASED ARGINASE ACTIVITY IN AORTA OF MINERALOCORTICOID-SALT HYPERTENSIVE RATS
Rodriguez, S., Richert, L., & Berthelot, A. (2000) · Clinical and Experimental Hypertension · doi:10.1081/ceh-100100063 · Cited by 47
Cited by
The Vascular Endothelium and Human Diseases
Rajendran, P., Rengarajan, T., Thangavel, J., Nishigaki, Y., Sakthisekaran, D., Sethi, G., & Nishigaki, I. (2013) · International Journal of Biological Sciences · doi:10.7150/ijbs.7502 · Cited by 1,467
Endothelial dysfunction and vascular disease - a 30th anniversary update
Vanhoutte, P. M., Shimokawa, H., Feletou, M., & Tang, E. H. C. (2017) · Acta Physiologica · doi:10.1111/apha.12646 · Cited by 937
Oxidative stress in chronic kidney disease
Daenen, K., Andries, A., Mekahli, D., Van Schepdael, A., Jouret, F., & Bammens, B. (2019) · Pediatric Nephrology · doi:10.1007/s00467-018-4005-4 · Cited by 882
Endothelial dysfunction: a multifaceted disorder (The Wiggers Award Lecture)
Félétou, M., & Vanhoutte, P. M. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00292.2006 · Cited by 818
Endothelial dysfunction and vascular disease
Vanhoutte, P. M., Shimokawa, H., Tang, E. H. C., & Feletou, M. (2009) · Acta Physiologica · doi:10.1111/j.1748-1716.2009.01964.x · Cited by 806
Metadata
- Authors
- Perticone, F., Sciacqua, A., Maio, R., Perticone, M., Maas, R., Boger, R. H., Tripepi, G., Sesti, G., & Zoccali, C.
- Venue
- Journal of the American College of Cardiology
- Publisher
- Elsevier BV
- Published
- 2005-08
- Volume
- 46
- Issue
- 3
- Pages
- 518-523
- ISSN
- 0735-1097 (ISSN-L)
- OpenAlex
- W2040643466
- Cited by
- 271
- References
- 42
- FWCI
- 10.58
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.